CN54gp140 HIV vaccine: Phase I started

Investigators from the universities, the Medical Research Council clinical trial unit and IDRI began the U.K. Phase I MUCOVAC2 trial of CN54gp140 in 36 healthy women volunteers ages 18-45 years. The s...